Put companies on watchlist
Cherry SE
ISIN: DE000A3CRRN9
WKN: A3CRRN
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Cherry SE · ISIN: DE000A3CRRN9 · EQS - adhoc news (74 News)
Country: Germany · Primary market: Germany · EQS NID: 1888553
24 April 2024 04:17PM

Cherry SE recognizes asset impairment for 2023; no impact on preliminary adjusted 2023 EBITDA and cash flow position as well as the forecast for the 2024 financial year


EQS-Ad-hoc: Cherry SE / Key word(s): Miscellaneous
Cherry SE: Cherry SE recognizes asset impairment for 2023; no impact on preliminary adjusted 2023 EBITDA and cash flow position as well as the forecast for the 2024 financial year

24-Apr-2024 / 16:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


PUBLICATION OF AN INSIDE INFORMATION ACC. TO ARTICLE 17 OF THE REGULATION (EU) NO. 596/2014

Cherry SE recognizes asset impairment for 2023; no impact on preliminary adjusted 2023 EBITDA and cash flow position as well as the forecast for the 2024 financial year

Munich, April 24 2024 – Cherry SE expects further asset impairments (intangible assets, and PP&E), mainly on goodwill, in the total amount of approximately EUR 96 million while preparing the 2023 consolidated financial statements.

In close coordination with the newly mandated auditor, Cherry SE is making an adjustment to the aforementioned assets, which reflects the correction of the 2023 last quarter results and the planning for 2024 that have already been communicated in the company announcements of January 31, 2024, and February 27, 2024. This step also marks the conclusion of the historical assumptions regarding the future development of the company and is part of the series of management measures currently aligning the company for competitiveness and future viability.

The impairment reduces the consolidated operating result (EBIT*) for the 2023 financial year by the same amount. The impairment - which is by definition a non-cash item - has no impact on the key performance indicators revenue and adjusted EBITDA margin*.

 

*The definition of EBIT and of the adjusted EBITDA margin can be found on pages 27 and 37 of the Annual Report 2022 of Cherry SE, which is available at https://ir.cherry.de/.

 

Notifying person: Oliver Kaltner, Chairman of the Management Board

 

 



End of Inside Information

24-Apr-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cherry SE
Rosental 7, c/o Mindspace
80331 Munich
Germany
ISIN: DE000A3CRRN9
WKN: A3CRRN
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1888553

 
End of Announcement EQS News Service

1888553  24-Apr-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1888553&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Cherry SE
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.